DOLUTEGRAVIR SODIUM AND RILPIVIRINE HYDROCHLORIDE

DOLUTEGRAVIR SODIUM AND RILPIVIRINE HYDROCHLORIDE was reported 1764 times

DOLUTEGRAVIR SODIUM AND RILPIVIRINE HYDROCHLORIDE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 PROVIDENCIA URINARY TRACT INFECTION 1 0.5000
1 MALE REPRODUCTIVE TRACT NEOPLASM 1 0.1667
2 CIRCULATING ANTICOAGULANT 2 0.1053
3 COELIAC ARTERY ANEURYSM 1 0.0417
4 BONE DEMINERALISATION 44 0.0415
5 RETIREMENT 1 0.0400
6 NEPHROANGIOSCLEROSIS 6 0.0373
7 PERITONEAL DIALYSATE LEAKAGE 1 0.0303
8 FEMORAL NERVE INJURY 2 0.0278
9 KARYOTYPE ANALYSIS ABNORMAL 3 0.0275
10 CONGENITAL HIV INFECTION 1 0.0256
11 VIRAL LOAD ABNORMAL 4 0.0229
12 JOINT DISLOCATION POSTOPERATIVE 1 0.0222
13 FEAR-RELATED AVOIDANCE OF ACTIVITIES 3 0.0197
14 PLASMA CELL DISORDER 1 0.0196
15 HIV ASSOCIATED NEPHROPATHY 1 0.0196
16 HIV-ASSOCIATED NEUROCOGNITIVE DISORDER 2 0.0180
17 TOXIC NEUROPATHY 7 0.0178
18 SEDATIVE THERAPY 1 0.0175
19 EXPLORATORY OPERATION 2 0.0155
20 MUSCULOSKELETAL PROCEDURAL COMPLICATION 1 0.0152
21 VIRAL LOAD INCREASED 53 0.0136
22 FAT REDISTRIBUTION 3 0.0129
23 SOCIOECONOMIC PRECARITY 2 0.0116
24 INFUSION SITE STREAKING 1 0.0115
25 MAY-THURNER SYNDROME 2 0.0112
26 TUBERCULOMA OF CENTRAL NERVOUS SYSTEM 2 0.0110
27 NATURAL KILLER CELL COUNT DECREASED 1 0.0109
28 PULMONARY AMYLOIDOSIS 1 0.0109
29 EXCESSIVE EXERCISE 1 0.0105
30 T-LYMPHOCYTE COUNT DECREASED 7 0.0103
31 BLOOD HIV RNA INCREASED 18 0.0099
32 INTESTINAL CONGESTION 1 0.0096
33 ANHEDONIA 251 0.0095
34 POEMS SYNDROME 1 0.0095
35 CD4 LYMPHOCYTES ABNORMAL 2 0.0095
36 CANCER IN REMISSION 2 0.0083
37 INCARCERATED INGUINAL HERNIA 1 0.0082
38 PNEUMOCOCCAL BACTERAEMIA 1 0.0079
39 CHORIORETINITIS 5 0.0078
40 CD19 LYMPHOCYTES DECREASED 1 0.0077
41 HUMAN IMMUNODEFICIENCY VIRUS TRANSMISSION 2 0.0072
42 MYOMECTOMY 1 0.0070
43 PLEUROPERITONEAL COMMUNICATION 1 0.0070
44 OROPHARYNGEAL SQUAMOUS CELL CARCINOMA 1 0.0069
45 SYPHILIS 5 0.0069
46 BLOOD TRIGLYCERIDES ABNORMAL 6 0.0068
47 VIRAEMIA 9 0.0065
48 OSTEOMALACIA 10 0.0065
49 GLOMERULOSCLEROSIS 4 0.0063
50 ELECTROCARDIOGRAM QT INTERVAL ABNORMAL 3 0.0060
51 FANCONI SYNDROME ACQUIRED 10 0.0057
52 FOETAL HEART RATE DECELERATION ABNORMALITY 4 0.0057
53 CHRONIC KIDNEY DISEASE-MINERAL AND BONE DISORDER 6 0.0056
54 DRUG RESISTANCE MUTATION 1 0.0056
55 CD4 LYMPHOCYTES DECREASED 12 0.0056
56 HYPEREOSINOPHILIC SYNDROME 3 0.0055
57 ECONOMIC PROBLEM 84 0.0055
58 CYSTITIS RADIATION 1 0.0052
59 CD8 LYMPHOCYTES DECREASED 1 0.0050
60 PERIORBITAL DISORDER 1 0.0049
61 PSEUDOCELLULITIS 1 0.0047
62 VIROLOGIC FAILURE 25 0.0046
63 VIRAL MUTATION IDENTIFIED 17 0.0046
64 SEXUALLY TRANSMITTED DISEASE 2 0.0046
65 END STAGE RENAL DISEASE 83 0.0045
66 OSTEOPENIA 69 0.0045
67 FOREARM FRACTURE 3 0.0043
68 RENAL CORTICAL NECROSIS 1 0.0043
69 CD4 LYMPHOCYTES INCREASED 1 0.0043
70 GLOMERULONEPHRITIS MEMBRANOUS 5 0.0043
71 LIPIDS ABNORMAL 3 0.0041
72 BODY MASS INDEX ABNORMAL 1 0.0041
73 DYSLIPIDAEMIA 20 0.0039
74 RECTAL NEOPLASM 1 0.0038
75 HYPERTENSIVE NEPHROPATHY 4 0.0037
76 EYELID OPERATION 1 0.0037
77 FACIAL WASTING 1 0.0037
78 HEPATITIS B SURFACE ANTIGEN POSITIVE 1 0.0036
79 EXCESSIVE SKIN 1 0.0035
80 RENAL TUBULAR DYSFUNCTION 2 0.0035
81 CONTRAINDICATED DRUG PRESCRIBED 1 0.0035
82 PRODUCT USE IN UNAPPROVED THERAPEUTIC ENVIRONMENT 3 0.0034
83 BREAST ENGORGEMENT 1 0.0034
84 LIPODYSTROPHY ACQUIRED 7 0.0033
85 SITTING DISABILITY 2 0.0032
86 HYPERPARATHYROIDISM SECONDARY 8 0.0032
87 BREAST HAEMORRHAGE 1 0.0030
88 NEPHROGENIC ANAEMIA 14 0.0030
89 ACUTE HEPATITIS B 1 0.0030
90 QUALITY OF LIFE DECREASED 40 0.0030
91 DECREASED ACTIVITY 32 0.0030
92 WAIST CIRCUMFERENCE INCREASED 3 0.0029
93 EOSINOPHILIC FASCIITIS 1 0.0029
94 URETEROLITHIASIS 3 0.0029
95 PATHOGEN RESISTANCE 26 0.0028
96 MICROSPORIDIA INFECTION 1 0.0028
97 GLOMERULAR FILTRATION RATE ABNORMAL 4 0.0028
98 ESCHERICHIA URINARY TRACT INFECTION 12 0.0028
99 CHRONIC KIDNEY DISEASE 204 0.0027
100 BONE DENSITY DECREASED 83 0.0026
101 FAT TISSUE DECREASED 1 0.0026
102 HEARING DISABILITY 1 0.0026
103 PANCREATOLITHIASIS 1 0.0025
104 TINEA PEDIS 4 0.0025
105 SHOULDER FRACTURE 4 0.0024
106 BIOPSY LIVER 1 0.0024
107 ENDOMETRIAL DISORDER 1 0.0024
108 AORTIC VALVE REPLACEMENT 3 0.0024
109 HEPATITIS A 2 0.0024
110 MICTURITION DISORDER 8 0.0023
111 THALAMUS HAEMORRHAGE 2 0.0023
112 PROSTATITIS 7 0.0023
113 EMOTIONAL DISTRESS 278 0.0023
114 MITOCHONDRIAL CYTOPATHY 1 0.0023
115 DEGENERATIVE BONE DISEASE 1 0.0023
116 OSTEOPOROSIS 92 0.0022
117 BODY MASS INDEX INCREASED 3 0.0022
118 ANAEMIA OF CHRONIC DISEASE 2 0.0022
119 RENAL TRANSPLANT 8 0.0022
120 MONONEUROPATHY MULTIPLEX 1 0.0022
121 GALLBLADDER RUPTURE 1 0.0022
122 GASTROINTESTINAL STOMA OUTPUT INCREASED 1 0.0021
123 INTENSIVE CARE 3 0.0021
124 LIPOATROPHY 2 0.0021
125 INFUSION SITE HAEMATOMA 1 0.0021
126 FAT TISSUE INCREASED 3 0.0021
127 GENOTYPE DRUG RESISTANCE TEST POSITIVE 2 0.0019
128 ACQUIRED IMMUNODEFICIENCY SYNDROME 1 0.0019
129 SKIN CANDIDA 1 0.0019
130 HYPERLIPASAEMIA 1 0.0019
131 HEPATITIS B REACTIVATION 6 0.0019
132 COATING IN MOUTH 1 0.0019
133 INAPPROPRIATE SCHEDULE OF PRODUCT DISCONTINUATION 1 0.0019
134 FRACTURE PAIN 1 0.0019
135 BODY FAT DISORDER 1 0.0018
136 INTERTRIGO 1 0.0018
137 MORNING SICKNESS 1 0.0018
138 NEPHROPATHY 17 0.0018
139 LIFE SUPPORT 1 0.0018
140 BURNING MOUTH SYNDROME 1 0.0018
141 MULTIPLE FRACTURES 29 0.0018
142 COLLAGEN DISORDER 1 0.0017
143 SELF-INJURIOUS IDEATION 7 0.0017
144 ARTERIOVENOUS FISTULA SITE COMPLICATION 1 0.0017
145 SLEEP TERROR 7 0.0017
146 HIV INFECTION 5 0.0017
147 PALATAL DISORDER 1 0.0017
148 HYPERTENSIVE HEART DISEASE 3 0.0016
149 OESOPHAGEAL ATRESIA 1 0.0016
150 NEUROPATHIC ARTHROPATHY 1 0.0015
151 VITAMIN D DEFICIENCY 15 0.0015
152 PROTEIN TOTAL ABNORMAL 2 0.0015
153 SHORT-BOWEL SYNDROME 1 0.0015
154 PROTEINURIA 29 0.0015
155 HIV TEST POSITIVE 1 0.0015
156 PERSONAL RELATIONSHIP ISSUE 1 0.0015
157 HEPATITIS B DNA INCREASED 1 0.0015
158 HEAD AND NECK CANCER 1 0.0015
159 HYPERURICAEMIA 6 0.0015
160 HYPERPARATHYROIDISM 3 0.0015
161 ANGULAR CHEILITIS 1 0.0014
162 HYPOSPADIAS 3 0.0014
163 LATENT TUBERCULOSIS 3 0.0014
164 ALANINE AMINOTRANSFERASE ABNORMAL 3 0.0014
165 ALPHA 1 FOETOPROTEIN INCREASED 1 0.0014
166 CERVICAL RADICULOPATHY 1 0.0014
167 GLOMERULAR FILTRATION RATE DECREASED 17 0.0014
168 TEMPERATURE REGULATION DISORDER 3 0.0013
169 ENTEROVESICAL FISTULA 1 0.0013
170 ASPARTATE AMINOTRANSFERASE ABNORMAL 2 0.0013
171 NEPHROTIC SYNDROME 9 0.0013
172 ARTERIAL RUPTURE 1 0.0013
173 HAEMANGIOMA 3 0.0013
174 INFUSION SITE INFECTION 3 0.0013
175 SKIN NEOPLASM EXCISION 1 0.0013
176 LABORATORY TEST INTERFERENCE 1 0.0013
177 TOOTH LOSS 26 0.0013
178 HERPES ZOSTER DISSEMINATED 1 0.0012
179 GLOMERULAR FILTRATION RATE INCREASED 1 0.0012
180 INTERCEPTED PRODUCT DISPENSING ERROR 2 0.0012
181 RESUSCITATION 2 0.0012
182 STRESS CARDIOMYOPATHY 7 0.0012
183 CONTRAINDICATED PRODUCT PRESCRIBED 2 0.0012
184 ENZYME LEVEL INCREASED 1 0.0012
185 KIDNEY FIBROSIS 2 0.0012
186 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 55 0.0011
187 PARVOVIRUS B19 INFECTION 1 0.0011
188 HEART TRANSPLANT 1 0.0011
189 SKIN WRINKLING 3 0.0011
190 SELECTIVE EATING DISORDER 1 0.0011
191 DRUG LEVEL ABOVE THERAPEUTIC 5 0.0011
192 SPINAL COMPRESSION FRACTURE 9 0.0011
193 PRODUCT APPEARANCE CONFUSION 1 0.0011
194 PREMATURE MENOPAUSE 1 0.0011
195 ENDOTRACHEAL INTUBATION 3 0.0011
196 PULPITIS DENTAL 1 0.0011
197 FOOT FRACTURE 20 0.0011
198 OSTEOPOROTIC FRACTURE 2 0.0010
199 PARTNER STRESS 1 0.0010
200 INFUSION SITE NODULE 1 0.0010
201 VASCULAR GRAFT 3 0.0010
202 HYPERVIGILANCE 1 0.0010
203 LOW DENSITY LIPOPROTEIN INCREASED 8 0.0010
204 ANAL CANCER 1 0.0010
205 ADRENOCORTICAL INSUFFICIENCY ACUTE 2 0.0010
206 RENAL TUBULAR NECROSIS 10 0.0010
207 RESPIRATORY ACIDOSIS 4 0.0010
208 PYURIA 1 0.0010
209 RENAL CYST 8 0.0010
210 PRODUCT DOSE OMISSION ISSUE 296 0.0010
211 HIGH DENSITY LIPOPROTEIN INCREASED 1 0.0010
212 ANXIETY 285 0.0010
213 ANTISOCIAL BEHAVIOUR 1 0.0010
214 CREATININE RENAL CLEARANCE DECREASED 4 0.0010
215 GASTRECTOMY 1 0.0010
216 HEPATITIS B 6 0.0010
217 RENAL FAILURE 132 0.0010
218 AUTONOMIC NEUROPATHY 1 0.0010
219 EAR HAEMORRHAGE 2 0.0010
220 BLOOD CREATININE INCREASED 64 0.0010
221 CAROTID ARTERIOSCLEROSIS 1 0.0010
222 FOETAL DEATH 5 0.0010
223 CARPAL TUNNEL DECOMPRESSION 1 0.0009
224 PANCREATIC MASS 1 0.0009
225 BONE LOSS 14 0.0009
226 GALLBLADDER ENLARGEMENT 1 0.0009
227 GASTRIC BYPASS 2 0.0009
228 RENAL TUBULAR ACIDOSIS 2 0.0009
229 RENAL IMPAIRMENT 77 0.0009
230 INFUSION SITE HAEMORRHAGE 3 0.0009
231 BIPOLAR I DISORDER 2 0.0009
232 IMMUNOSUPPRESSANT DRUG LEVEL INCREASED 3 0.0009
233 NEPHROSCLEROSIS 1 0.0009
234 FEAR OF DEATH 2 0.0009
235 DYSLEXIA 1 0.0009
236 PALMAR ERYTHEMA 1 0.0009
237 REACTION TO EXCIPIENT 2 0.0009
238 MUCOSAL HAEMORRHAGE 1 0.0009
239 RALES 5 0.0009
240 NECK SURGERY 2 0.0009
241 TIBIA FRACTURE 4 0.0009
242 DIALYSIS 12 0.0008
243 ANKLE FRACTURE 13 0.0008
244 RECTAL PROLAPSE 1 0.0008
245 RENAL TUBULAR INJURY 1 0.0008
246 INTERVERTEBRAL DISC OPERATION 1 0.0008
247 GASTROINTESTINAL TUBE INSERTION 2 0.0008
248 DISSEMINATED TUBERCULOSIS 2 0.0008
249 SKELETAL INJURY 8 0.0008
250 RETINAL DEGENERATION 1 0.0008
251 LIBIDO DISORDER 1 0.0008
252 ACQUIRED GENE MUTATION 1 0.0008
253 GLYCOSURIA 1 0.0007
254 EFFUSION 1 0.0007
255 RIB FRACTURE 15 0.0007
256 RENAL ARTERY STENOSIS 1 0.0007
257 SOCIAL PROBLEM 3 0.0007
258 ATYPICAL MYCOBACTERIAL INFECTION 1 0.0007
259 GENITAL RASH 1 0.0007
260 DUODENAL ULCER HAEMORRHAGE 2 0.0007
261 EXERCISE TOLERANCE DECREASED 4 0.0007
262 FIBULA FRACTURE 2 0.0007
263 HYPERTONIC BLADDER 2 0.0007
264 LABELLED DRUG-DRUG INTERACTION ISSUE 1 0.0007
265 TOOTH INJURY 3 0.0007
266 BLOOD CREATINE INCREASED 3 0.0007
267 NEPHRECTOMY 1 0.0007
268 MENTAL FATIGUE 1 0.0007
269 LOSS OF EMPLOYMENT 2 0.0007
270 RENAL PAIN 7 0.0007
271 ABDOMINAL HERNIA 3 0.0007
272 INJECTION SITE PARAESTHESIA 1 0.0007
273 DAYDREAMING 1 0.0006
274 GASTROSTOMY 1 0.0006
275 BACTERIAL VAGINOSIS 1 0.0006
276 GASTROINTESTINAL STOMA COMPLICATION 1 0.0006
277 INTESTINAL ULCER 1 0.0006
278 RENAL DISORDER 29 0.0006
279 HYPERCHOLESTEROLAEMIA 6 0.0006
280 FRUSTRATION TOLERANCE DECREASED 5 0.0006
281 RENAL INJURY 18 0.0006
282 INABILITY TO AFFORD MEDICATION 6 0.0006
283 PROTEIN URINE PRESENT 3 0.0006
284 EDUCATIONAL PROBLEM 1 0.0006
285 GASTRIC DILATATION 1 0.0006
286 LAZINESS 1 0.0006
287 FEMORAL NECK FRACTURE 3 0.0006
288 POLYNEUROPATHY 7 0.0006
289 PERIPHERAL COLDNESS 8 0.0006
290 AMYLOIDOSIS 1 0.0006
291 HEPATITIS C 7 0.0006
292 ACUTE KIDNEY INJURY 88 0.0006
293 FOOD INTERACTION 1 0.0006
294 PANCREATIC FAILURE 1 0.0006
295 LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR 5 0.0006
296 JUGULAR VEIN THROMBOSIS 1 0.0006
297 SCLERODERMA 2 0.0005
298 DRUG RESISTANCE 14 0.0005
299 LYMPH NODE PAIN 1 0.0005
300 BONE DENSITY ABNORMAL 2 0.0005
301 ARTERIOSCLEROSIS 5 0.0005
302 PERONEAL NERVE PALSY 3 0.0005
303 DEPRESSION 120 0.0005
304 MECHANICAL VENTILATION 1 0.0005
305 CLAVICLE FRACTURE 2 0.0005
306 GINGIVAL RECESSION 1 0.0005
307 PATIENT DISSATISFACTION WITH TREATMENT 1 0.0005
308 FOOD ALLERGY 4 0.0005
309 CONVERSION DISORDER 1 0.0005
310 IMPAIRED WORK ABILITY 11 0.0005
311 DYSSTASIA 15 0.0005
312 CYTOMEGALOVIRUS CHORIORETINITIS 1 0.0005
313 PYELONEPHRITIS ACUTE 1 0.0005
314 JOINT NOISE 1 0.0005
315 PROSTATOMEGALY 2 0.0005
316 THERAPY CHANGE 5 0.0005
317 PAIN 312 0.0005
318 DIPLEGIA 1 0.0005
319 GENE MUTATION 1 0.0005
320 PRODUCT DISPENSING ERROR 11 0.0005
321 AZOTAEMIA 2 0.0005
322 CARDIAC DISCOMFORT 1 0.0005
323 LIBIDO INCREASED 1 0.0005
324 BREAST DISORDER 1 0.0005
325 OSTEONECROSIS 16 0.0005
326 POLYCYTHAEMIA 1 0.0005
327 INTERNATIONAL NORMALISED RATIO FLUCTUATION 1 0.0005
328 WEIGHT FLUCTUATION 5 0.0005
329 INFUSION SITE SWELLING 3 0.0005
330 NEUROGENIC BLADDER 1 0.0005
331 INFUSION SITE PAIN 6 0.0005
332 HYPERPHOSPHATAEMIA 1 0.0005
333 JAW FRACTURE 1 0.0005
334 OESOPHAGEAL VARICES HAEMORRHAGE 1 0.0005
335 DIABETIC NEPHROPATHY 1 0.0005
336 COLONOSCOPY 1 0.0005
337 DANDRUFF 1 0.0005
338 RENAL COLIC 1 0.0004
339 HAEMATOCRIT INCREASED 1 0.0004
340 LICHENOID KERATOSIS 1 0.0004
341 FLAT AFFECT 1 0.0004
342 FEELING OF DESPAIR 2 0.0004
343 PATELLA FRACTURE 1 0.0004
344 HYPERKALAEMIA 15 0.0004
345 DISTURBANCE IN SOCIAL BEHAVIOUR 1 0.0004
346 VENTRICULAR TACHYCARDIA 7 0.0004
347 INGROWING NAIL 1 0.0004
348 POISONING DELIBERATE 4 0.0004
349 GAIT INABILITY 14 0.0004
350 OXYGEN CONSUMPTION INCREASED 1 0.0004
351 RADIUS FRACTURE 1 0.0004
352 HUMERUS FRACTURE 2 0.0004
353 NEPHROLITHIASIS 19 0.0004
354 RASH VESICULAR 2 0.0004
355 BURSITIS 5 0.0004
356 COELIAC DISEASE 4 0.0004
357 DECREASED IMMUNE RESPONSIVENESS 4 0.0004
358 IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME 2 0.0004
359 CATHETER SITE HAEMORRHAGE 1 0.0004
360 PRODUCT CONTAMINATION PHYSICAL 1 0.0004
361 HAEMORRHAGE URINARY TRACT 1 0.0004
362 ABNORMAL UTERINE BLEEDING 1 0.0004
363 LIPOMA 1 0.0004
364 HERNIA REPAIR 1 0.0004
365 POLLAKIURIA 16 0.0004
366 FOLLICULITIS 4 0.0004
367 BLOOD POTASSIUM ABNORMAL 1 0.0004
368 GASTROINTESTINAL MOTILITY DISORDER 2 0.0004
369 FOOD POISONING 2 0.0004
370 SKIN DISCOMFORT 1 0.0004
371 FRACTURE 7 0.0004
372 CHONDROPATHY 1 0.0004
373 ASTHENOPIA 2 0.0004
374 RHINALGIA 1 0.0004
375 BONE PAIN 21 0.0004
376 DRUG TOLERANCE DECREASED 1 0.0004
377 RENAL TUBULAR DISORDER 1 0.0004
378 UPPER LIMB FRACTURE 7 0.0004
379 LIP PAIN 1 0.0003
380 MOBILITY DECREASED 25 0.0003
381 FINE MOTOR SKILL DYSFUNCTION 1 0.0003
382 DYSPNOEA AT REST 1 0.0003
383 EOSINOPHILIA 6 0.0003
384 NEGATIVE THOUGHTS 1 0.0003
385 LIVER DISORDER 15 0.0003
386 EXPOSURE DURING PREGNANCY 21 0.0003
387 RHABDOMYOLYSIS 14 0.0003
388 WRIST FRACTURE 4 0.0003
389 MOUTH ULCERATION 7 0.0003
390 OROPHARYNGEAL DISCOMFORT 3 0.0003
391 BONE MARROW DISORDER 1 0.0003
392 BONE DISORDER 6 0.0003
393 NEURALGIA 8 0.0003
394 MASTICATION DISORDER 1 0.0003
395 INFUSION SITE PRURITUS 1 0.0003
396 HEPATOTOXICITY 7 0.0003
397 HEPATIC CYTOLYSIS 4 0.0003
398 LIVER ABSCESS 1 0.0003
399 OEDEMA MOUTH 1 0.0003
400 BREAST ENLARGEMENT 1 0.0003
401 PRODUCT FORMULATION ISSUE 2 0.0003
402 NEAR DEATH EXPERIENCE 1 0.0003
403 DIABETES MELLITUS 23 0.0003
404 SKIN INJURY 1 0.0003
405 LEFT VENTRICULAR DYSFUNCTION 2 0.0003
406 POTENTIATING DRUG INTERACTION 1 0.0003
407 TYPE 2 DIABETES MELLITUS 10 0.0003
408 NEUROPATHY PERIPHERAL 28 0.0003
409 INTERNATIONAL NORMALISED RATIO ABNORMAL 1 0.0003
410 HYPERTENSION 61 0.0003
411 HYPERTRANSAMINASAEMIA 2 0.0003
412 PRODUCT STORAGE ERROR 25 0.0003
413 DEPRESSIVE SYMPTOM 1 0.0003
414 HAND FRACTURE 2 0.0003
415 PROSTATE CANCER STAGE IV 1 0.0003
416 PRODUCT USE ISSUE 53 0.0003
417 APPENDICECTOMY 1 0.0003
418 INTERCEPTED PRODUCT STORAGE ERROR 1 0.0003
419 HIP FRACTURE 9 0.0003
420 GOUT 5 0.0003
421 BACK INJURY 3 0.0003
422 SEPTIC SHOCK 12 0.0003
423 SEBORRHOEA 1 0.0003
424 GAIT DISTURBANCE 52 0.0003
425 CEREBRAL DISORDER 2 0.0003
426 NEPHROPATHY TOXIC 3 0.0003
427 PROTEIN TOTAL DECREASED 1 0.0003
428 CATHETER SITE INFECTION 1 0.0003
429 CONTRAINDICATED PRODUCT ADMINISTERED 8 0.0003
430 MUSCULOSKELETAL DISORDER 5 0.0003
431 GASTRIC INFECTION 1 0.0003
432 PRODUCT DOSE OMISSION 17 0.0003
433 NIGHTMARE 9 0.0003
434 CARDIOPULMONARY FAILURE 1 0.0003
435 TREATMENT NONCOMPLIANCE 14 0.0003
436 OESOPHAGEAL PAIN 1 0.0003
437 GINGIVAL PAIN 2 0.0003
438 HYPERLIPIDAEMIA 3 0.0003
439 METABOLIC ACIDOSIS 8 0.0002
440 MUSCLE HAEMORRHAGE 1 0.0002
441 PRODUCT ADMINISTRATION ERROR 5 0.0002
442 PRODUCT DOSE OMISSION IN ERROR 7 0.0002
443 HYPERGLYCAEMIA 9 0.0002
444 RECURRENT CANCER 1 0.0002
445 DEMYELINATION 1 0.0002
446 BLOOD CREATINE PHOSPHOKINASE INCREASED 7 0.0002
447 APPLICATION SITE EXFOLIATION 1 0.0002
448 LEG AMPUTATION 1 0.0002
449 HEMIPLEGIA 2 0.0002
450 CANDIDA INFECTION 4 0.0002
451 WEIGHT INCREASED 53 0.0002
452 LIP OEDEMA 1 0.0002
453 MUSCLE FATIGUE 1 0.0002
454 BUNDLE BRANCH BLOCK LEFT 1 0.0002
455 CARDIAC FAILURE CHRONIC 1 0.0002
456 INTERVERTEBRAL DISC DISORDER 1 0.0002
457 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 4 0.0002
458 LIVER FUNCTION TEST INCREASED 5 0.0002
459 SKIN HYPERPIGMENTATION 2 0.0002
460 MUSCLE STRAIN 2 0.0002
461 FAECES DISCOLOURED 5 0.0002
462 SUICIDAL IDEATION 21 0.0002
463 INTERVERTEBRAL DISC PROTRUSION 5 0.0002
464 DYSPHEMIA 1 0.0002
465 INTENTIONAL DEVICE MISUSE 1 0.0002
466 LIGAMENT RUPTURE 1 0.0002
467 TRANSAMINASES INCREASED 5 0.0002
468 RHINITIS ALLERGIC 1 0.0002
469 ELECTROCARDIOGRAM QT PROLONGED 8 0.0002
470 OPTIC NEURITIS 2 0.0002
471 HAEMOGLOBIN INCREASED 1 0.0002
472 INJECTION SITE PAPULE 1 0.0002
473 IMMUNE THROMBOCYTOPENIA 1 0.0002
474 PNEUMONIA BACTERIAL 2 0.0002
475 DYSURIA 8 0.0002
476 ABNORMAL DREAMS 6 0.0002
477 EYE OPERATION 1 0.0002
478 PRODUCT DISTRIBUTION ISSUE 2 0.0002
479 AGRANULOCYTOSIS 4 0.0002
480 ANAEMIA 41 0.0002
481 DRUG INTERACTION 34 0.0002
482 FLANK PAIN 2 0.0002
483 ANGINA PECTORIS 6 0.0002
484 HYPERSOMNIA 6 0.0002
485 LOWER LIMB FRACTURE 4 0.0002
486 HORMONE LEVEL ABNORMAL 1 0.0002
487 RENAL CELL CARCINOMA 1 0.0002
488 DYSPEPSIA 20 0.0002
489 ABDOMINAL TENDERNESS 1 0.0002
490 IMMUNODEFICIENCY 3 0.0002
491 ANEURYSM 1 0.0002
492 HIP ARTHROPLASTY 3 0.0002
493 BENIGN PROSTATIC HYPERPLASIA 1 0.0002
494 TREATMENT FAILURE 16 0.0002
495 NERVOUS SYSTEM DISORDER 6 0.0002
496 CATATONIA 1 0.0002
497 HEAD INJURY 6 0.0002
498 INCONTINENCE 2 0.0002
499 CLOSTRIDIUM DIFFICILE COLITIS 2 0.0002
500 RETCHING 4 0.0002
501 JOINT INJURY 4 0.0002
502 INTESTINAL RESECTION 1 0.0002
503 BALANCE DISORDER 16 0.0002
504 NORMAL NEWBORN 1 0.0002
505 MENTAL DISORDER 8 0.0002
506 PULMONARY THROMBOSIS 2 0.0002
507 NONSPECIFIC REACTION 1 0.0002
508 TOOTH FRACTURE 2 0.0002
509 DRUG LEVEL BELOW THERAPEUTIC 1 0.0002
510 GASTRIC ULCER HAEMORRHAGE 1 0.0002
511 FOOT DEFORMITY 2 0.0002
512 LEUKOPENIA 9 0.0002
513 SKIN DISORDER 6 0.0002
514 NERVE INJURY 2 0.0002
515 ALANINE AMINOTRANSFERASE INCREASED 11 0.0002
516 PRODUCT LEAKAGE 1 0.0002
517 OCULAR DISCOMFORT 2 0.0002
518 INTENTIONAL DOSE OMISSION 5 0.0002
519 SCAB 2 0.0002
520 CHOLECYSTECTOMY 2 0.0002
521 EXTRA DOSE ADMINISTERED 7 0.0002
522 METABOLIC DISORDER 1 0.0002
523 BACK PAIN 40 0.0002
524 PERIPHERAL SENSORY NEUROPATHY 1 0.0002
525 HYPERTRIGLYCERIDAEMIA 1 0.0002
526 ENERGY INCREASED 1 0.0002
527 GLUCOSE TOLERANCE IMPAIRED 1 0.0002
528 INSOMNIA 45 0.0002
529 SINUS HEADACHE 1 0.0002
530 SKIN EXFOLIATION 14 0.0002
531 CONDITION AGGRAVATED 50 0.0002
532 HAEMORRHAGE 17 0.0002
533 PRESCRIPTION DRUG USED WITHOUT A PRESCRIPTION 1 0.0002
534 HEPATIC ENZYME INCREASED 11 0.0002
535 HEPATIC STEATOSIS 3 0.0002
536 TOOTH EXTRACTION 2 0.0002
537 FATIGUE 125 0.0002
538 DYSPNOEA EXERTIONAL 6 0.0002
539 MULTIPLE INJURIES 1 0.0002
540 FLATULENCE 9 0.0002
541 BLOOD URINE PRESENT 3 0.0002
542 FEELING JITTERY 3 0.0002
543 MOOD SWINGS 5 0.0002
544 GLAUCOMA 3 0.0002
545 ERECTILE DYSFUNCTION 4 0.0002
546 PRESCRIBED OVERDOSE 3 0.0002
547 INCOHERENT 1 0.0002
548 RASH GENERALISED 4 0.0002
549 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 8 0.0002
550 NODULE 2 0.0002
551 REFUSAL OF TREATMENT BY PATIENT 1 0.0002
552 POLYP 1 0.0002
553 CORONAVIRUS INFECTION 1 0.0002
554 ARTERIOSCLEROSIS CORONARY ARTERY 1 0.0002
555 BLOOD PRESSURE ABNORMAL 3 0.0002
556 APPETITE DISORDER 1 0.0002
557 BLOOD CHOLESTEROL INCREASED 7 0.0002
558 SPINAL FRACTURE 3 0.0001
559 HOSPITALISATION 23 0.0001
560 POST-TRAUMATIC STRESS DISORDER 1 0.0001
561 FEAR 4 0.0001
562 PRODUCT PHYSICAL ISSUE 3 0.0001
563 LOSS OF CONSCIOUSNESS 19 0.0001
564 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 5 0.0001
565 MUSCLE SPASMS 27 0.0001
566 ACUTE HEPATIC FAILURE 2 0.0001
567 BLOOD TESTOSTERONE DECREASED 1 0.0001
568 EYE MOVEMENT DISORDER 1 0.0001
569 MATERNAL EXPOSURE DURING PREGNANCY 13 0.0001
570 LARGE INTESTINE POLYP 1 0.0001
571 FORMICATION 1 0.0001
572 DEMENTIA 4 0.0001
573 CARPAL TUNNEL SYNDROME 2 0.0001
574 BURNING SENSATION 10 0.0001
575 HYPOAESTHESIA 21 0.0001
576 HYPERTHYROIDISM 2 0.0001
577 MAJOR DEPRESSION 1 0.0001
578 GASTROOESOPHAGEAL REFLUX DISEASE 11 0.0001
579 MOUTH HAEMORRHAGE 1 0.0001
580 MELAENA 3 0.0001
581 BLINDNESS TRANSIENT 1 0.0001
582 HYPOPHOSPHATAEMIA 1 0.0001
583 OESOPHAGEAL CARCINOMA 4 0.0001
584 FEELING DRUNK 1 0.0001
585 HYDRONEPHROSIS 1 0.0001
586 PREMATURE BABY 4 0.0001
587 PRODUCT AVAILABILITY ISSUE 3 0.0001
588 ACIDOSIS 1 0.0001
589 BOWEL MOVEMENT IRREGULARITY 1 0.0001
590 DEVICE PHYSICAL PROPERTY ISSUE 1 0.0001
591 TENDONITIS 2 0.0001
592 APHTHOUS ULCER 1 0.0001
593 NICOTINE DEPENDENCE 1 0.0001
594 RASH 56 0.0001
595 AFFECTIVE DISORDER 1 0.0001
596 FURUNCLE 1 0.0001
597 PRODUCT PRESCRIBING ERROR 3 0.0001
598 HALLUCINATION, AUDITORY 2 0.0001
599 PREMATURE DELIVERY 2 0.0001
600 RASH ERYTHEMATOUS 6 0.0001
601 SENSORY DISTURBANCE 2 0.0001
602 RHINITIS 1 0.0001
603 CONFUSIONAL STATE 20 0.0001
604 MUSCLE DISORDER 1 0.0001
605 MUSCLE TIGHTNESS 2 0.0001
606 BACK DISORDER 2 0.0001
607 SHOCK HAEMORRHAGIC 1 0.0001
608 DECUBITUS ULCER 1 0.0001
609 BLINDNESS 5 0.0001
610 ENCEPHALOPATHY 3 0.0001
611 ABNORMAL FAECES 1 0.0001
612 CHOLELITHIASIS 4 0.0001
613 ESCHERICHIA INFECTION 1 0.0001
614 EMBOLISM 1 0.0001
615 FUNGAL INFECTION 4 0.0001
616 ASTHENIA 45 0.0001
617 LIVE BIRTH 1 0.0001
618 HAEMODIALYSIS 1 0.0001
619 DRUG USE DISORDER 1 0.0001
620 FACIAL PARALYSIS 1 0.0001
621 THERAPY CESSATION 6 0.0001
622 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 3 0.0001
623 CARDIAC OPERATION 1 0.0001
624 ANURIA 1 0.0001
625 PYELONEPHRITIS 1 0.0001
626 PAIN IN EXTREMITY 34 0.0001
627 ABDOMINAL DISTENSION 12 0.0001
628 ORTHOSTATIC HYPOTENSION 2 0.0001
629 JOINT STIFFNESS 3 0.0001
630 GROIN PAIN 1 0.0001
631 LUNG INFILTRATION 1 0.0001
632 BLOOD TRIGLYCERIDES INCREASED 2 0.0001
633 CARDIAC FAILURE CONGESTIVE 9 0.0001
634 THROMBOSIS 9 0.0001
635 MYALGIA 19 0.0001
636 PULMONARY OEDEMA 5 0.0001
637 HAEMARTHROSIS 1 0.0001
638 HEAVY MENSTRUAL BLEEDING 1 0.0001
639 CRYING 4 0.0001
640 BRAIN NEOPLASM 1 0.0001
641 RETINAL DETACHMENT 1 0.0001
642 INTERVERTEBRAL DISC DEGENERATION 1 0.0001
643 PARAESTHESIA 17 0.0001
644 PERSONALITY CHANGE 1 0.0001
645 AMNESIA 7 0.0001
646 NECK PAIN 6 0.0001
647 BACTERIAL INFECTION 2 0.0001
648 MIDDLE INSOMNIA 2 0.0001
649 ILLNESS 11 0.0001
650 TUBULOINTERSTITIAL NEPHRITIS 2 0.0001
651 PRODUCT PACKAGING ISSUE 1 0.0001
652 COMA 5 0.0001
653 SLEEP APNOEA SYNDROME 2 0.0001
654 WEIGHT DECREASED 29 0.0001
655 DRUG INTOLERANCE 10 0.0001
656 HERNIA 2 0.0001
657 ERUCTATION 2 0.0001
658 PNEUMONIA 33 0.0001
659 HOSPICE CARE 1 0.0001
660 DISABILITY 2 0.0001
661 TOXICITY TO VARIOUS AGENTS 17 0.0001
662 ABORTION SPONTANEOUS 4 0.0001
663 BLOOD POTASSIUM DECREASED 3 0.0001
664 BRAIN INJURY 1 0.0001
665 EMPHYSEMA 1 0.0001
666 HYPOTHERMIA 1 0.0001
667 FOETAL EXPOSURE DURING PREGNANCY 8 0.0001
668 EYELID PTOSIS 1 0.0001
669 FLUID RETENTION 5 0.0001
670 DRUG LEVEL DECREASED 1 0.0001
671 MOTOR DYSFUNCTION 1 0.0001
672 THERAPY INTERRUPTED 7 0.0001
673 INITIAL INSOMNIA 1 0.0001
674 PERIPHERAL SWELLING 15 0.0001
675 HELICOBACTER INFECTION 1 0.0001
676 GYNAECOMASTIA 3 0.0001
677 FEMUR FRACTURE 3 0.0001
678 POOR VENOUS ACCESS 1 0.0001
679 EYE DISCHARGE 1 0.0001
680 MUSCULOSKELETAL PAIN 5 0.0001
681 ABDOMINAL DISCOMFORT 16 0.0001
682 INJECTION SITE DISCOMFORT 1 0.0001
683 DYSPHAGIA 9 0.0001
684 HALLUCINATION, VISUAL 2 0.0001
685 PANCREATITIS 5 0.0001
686 MIGRAINE 9 0.0001
687 POOR QUALITY SLEEP 2 0.0001
688 PRURITUS GENERALISED 2 0.0001
689 ATRIAL FIBRILLATION 9 0.0001
690 ABDOMINAL PAIN UPPER 19 0.0001
691 BIPOLAR DISORDER 1 0.0001
692 SKIN LACERATION 1 0.0001
693 ARTHRALGIA 38 0.0001
694 BLOOD GLUCOSE FLUCTUATION 1 0.0001
695 GASTROINTESTINAL PAIN 1 0.0001
696 DENTAL CARIES 1 0.0001
697 STEVENS-JOHNSON SYNDROME 2 0.0001
698 TOOTH DISORDER 2 0.0001
699 URINARY RETENTION 3 0.0001
700 NEOPLASM MALIGNANT 6 0.0001
701 HYPERTENSIVE CRISIS 1 0.0001
702 MALNUTRITION 1 0.0001
703 THERAPEUTIC RESPONSE UNEXPECTED 4 0.0001
704 SKIN INFECTION 1 0.0001
705 ARTHRITIS 7 0.0001
706 PANCREATITIS ACUTE 2 0.0001
707 ANGER 3 0.0001
708 DERMATITIS CONTACT 1 0.0001
709 CONSTIPATION 19 0.0001
710 LETHARGY 5 0.0001
711 HYPERSENSITIVITY 16 0.0001
712 INJURY 6 0.0001
713 SEXUAL DYSFUNCTION 1 0.0001
714 SURGERY 5 0.0001
715 ATAXIA 1 0.0001
716 MUSCLE RIGIDITY 1 0.0001
717 MENTAL IMPAIRMENT 2 0.0001
718 DRY SKIN 11 0.0001
719 SCHIZOPHRENIA 1 0.0001
720 URINARY TRACT INFECTION 14 0.0001
721 NASOPHARYNGITIS 15 0.0001
722 INTERCEPTED PRODUCT PREPARATION ERROR 1 0.0001
723 HYPERCALCAEMIA 1 0.0001
724 CYST 1 0.0001
725 SECRETION DISCHARGE 1 0.0001
726 DERMATITIS ALLERGIC 1 0.0001
727 DIARRHOEA 51 0.0001
728 PRODUCT COMPLAINT 2 0.0001
729 INJECTION SITE IRRITATION 1 0.0001
730 DEVICE DEPLOYMENT ISSUE 1 0.0001
731 SEIZURE 9 0.0001
732 UNRESPONSIVE TO STIMULI 2 0.0001
733 SPEECH DISORDER 4 0.0001
734 IMMUNE SYSTEM DISORDER 1 0.0001
735 SARS-COV-2 TEST POSITIVE 1 0.0001
736 ADVERSE REACTION 1 0.0001
737 SWELLING 7 0.0001
738 CARDIAC FAILURE 6 0.0001
739 JOINT SWELLING 9 0.0001
740 DISTURBANCE IN ATTENTION 4 0.0001
741 COVID-19 13 0.0001
742 PULMONARY EMBOLISM 7 0.0001
743 MOOD ALTERED 2 0.0001
744 DEATH 63 0.0001
745 MALAISE 32 0.0001
746 SKIN LESION 2 0.0001
747 MEMORY IMPAIRMENT 10 0.0001
748 PROSTATIC SPECIFIC ANTIGEN INCREASED 1 0.0001
749 RESPIRATORY DISTRESS 2 0.0001
750 FALL 24 0.0001
751 ROAD TRAFFIC ACCIDENT 3 0.0001
752 APHONIA 1 0.0001
753 THROMBOCYTOPENIA 8 0.0001
754 BLISTER 4 0.0001
755 BLINDNESS UNILATERAL 1 0.0001
756 OSTEOARTHRITIS 3 0.0001
757 PAIN IN JAW 2 0.0001
758 HEADACHE 44 0.0001
759 GENERAL PHYSICAL HEALTH DETERIORATION 8 0.0001
760 HYPOKINESIA 1 0.0001
761 LIVER FUNCTION TEST ABNORMAL 2 0.0001
762 ANGIOEDEMA 3 0.0001
763 CARDIOMYOPATHY 1 0.0001
764 DRUG EFFECT LESS THAN EXPECTED 1 0.0001
765 SKIN HAEMORRHAGE 1 0.0001
766 PULMONARY MASS 1 0.0001
767 ADVERSE DRUG REACTION 6 0.0001
768 HALLUCINATION 5 0.0001
769 HEPATIC FAILURE 2 0.0001
770 INSURANCE ISSUE 1 0.0001
771 SKIN DISCOLOURATION 3 0.0001
772 HYPOKALAEMIA 3 0.0001
773 CEREBROVASCULAR ACCIDENT 11 0.0001
774 UPPER RESPIRATORY TRACT INFECTION 3 0.0001
775 LYMPHOMA 1 0.0001
776 SOMNOLENCE 13 0.0001
777 ABDOMINAL PAIN 15 0.0001
778 DELUSION 1 0.0001
779 BASAL CELL CARCINOMA 1 0.0001
780 RESPIRATORY TRACT CONGESTION 1 0.0001
781 OBESITY 1 0.0001
782 ABSCESS 1 0.0001
783 HYPOTHYROIDISM 2 0.0001
784 MOVEMENT DISORDER 2 0.0001
785 NIGHT SWEATS 2 0.0001
786 RHEUMATOID ARTHRITIS 7 0.0001
787 BLOOD POTASSIUM INCREASED 1 0.0001
788 LUNG DISORDER 3 0.0001
789 EYE DISORDER 2 0.0001
790 PSYCHOMOTOR HYPERACTIVITY 1 0.0001
791 EXPIRED PRODUCT ADMINISTERED 2 0.0001
792 VIRAL INFECTION 2 0.0001
793 BLOOD UREA INCREASED 1 0.0001
794 FACE OEDEMA 1 0.0001
795 HEMIPARESIS 1 0.0001
796 GASTRIC DISORDER 2 0.0001
797 MUSCULOSKELETAL DISCOMFORT 1 0.0001
798 PARANOIA 1 0.0001
799 INTENTIONAL PRODUCT MISUSE 5 0.0001
800 LYMPHADENOPATHY 2 0.0001
801 HEAD DISCOMFORT 1 0.0001
802 ASPARTATE AMINOTRANSFERASE INCREASED 3 0.0001
803 GALLBLADDER DISORDER 1 0.0001
804 CEREBRAL HAEMORRHAGE 2 0.0001
805 OEDEMA 3 0.0001
806 LEUKOCYTOSIS 1 0.0001
807 RESTLESS LEGS SYNDROME 1 0.0001
808 PANIC ATTACK 2 0.0001
809 RESTLESSNESS 2 0.0001
810 PRODUCT ADMINISTERED AT INAPPROPRIATE SITE 1 0.0001
811 AGITATION 4 0.0001
812 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 11 0.0001
813 FEELING ABNORMAL 13 0.0001
814 BLOOD GLUCOSE ABNORMAL 1 0.0001
815 PANCYTOPENIA 3 0.0001
816 HYPONATRAEMIA 3 0.0001
817 HEPATIC CIRRHOSIS 1 0.0001
818 MUSCULAR WEAKNESS 6 0.0001
819 COLITIS 2 0.0001
820 GASTRIC ULCER 1 0.0001
821 BLOOD PRESSURE INCREASED 8 0.0001
822 WHITE BLOOD CELL COUNT INCREASED 2 0.0001
823 POST PROCEDURAL COMPLICATION 1 0.0001
824 SEROTONIN SYNDROME 1 0.0001
825 ACUTE RESPIRATORY FAILURE 1 0.0001
826 NAUSEA 41 0.0001
827 PLASMA CELL MYELOMA 2 0.0001
828 CHOKING 1 0.0001
829 KIDNEY INFECTION 1 0.0001
830 SINUS DISORDER 1 0.0001
831 HAEMATOCRIT DECREASED 1 0.0001
832 CATARACT 3 0.0001
833 SYNCOPE 5 0.0000
834 SUICIDE ATTEMPT 3 0.0000
835 ILL-DEFINED DISORDER 3 0.0000
836 FEEDING DISORDER 1 0.0000
837 FEELING HOT 3 0.0000
838 LUNG NEOPLASM MALIGNANT 2 0.0000
839 INFECTION 7 0.0000
840 PULMONARY HYPERTENSION 1 0.0000
841 DERMATITIS 1 0.0000
842 KNEE ARTHROPLASTY 1 0.0000
843 EATING DISORDER 1 0.0000
844 PRURITUS 18 0.0000
845 IRRITABLE BOWEL SYNDROME 1 0.0000
846 SKIN CANCER 1 0.0000
847 PRODUCT PRESCRIBING ISSUE 1 0.0000
848 INFUSION RELATED REACTION 3 0.0000
849 INFLUENZA 5 0.0000
850 ORAL PAIN 1 0.0000
851 GASTROINTESTINAL DISORDER 4 0.0000
852 RASH PAPULAR 1 0.0000
853 THERAPY NON-RESPONDER 2 0.0000
854 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 8 0.0000
855 CHROMATURIA 1 0.0000
856 HEART RATE IRREGULAR 1 0.0000
857 ASTHMA 5 0.0000
858 DYSPNOEA 25 0.0000
859 INJECTION SITE REACTION 3 0.0000
860 SHOCK 1 0.0000
861 MUSCLE TWITCHING 1 0.0000
862 DECREASED APPETITE 10 0.0000
863 COUGH 12 0.0000
864 ARRHYTHMIA 2 0.0000
865 PRODUCTIVE COUGH 2 0.0000
866 URTICARIA 7 0.0000
867 DIABETIC KETOACIDOSIS 1 0.0000
868 LOCALISED INFECTION 1 0.0000
869 INTERSTITIAL LUNG DISEASE 2 0.0000
870 RESPIRATORY FAILURE 3 0.0000
871 PRESYNCOPE 1 0.0000
872 UNDERDOSE 3 0.0000
873 CEREBRAL INFARCTION 1 0.0000
874 CELLULITIS 2 0.0000
875 UNEVALUABLE EVENT 3 0.0000
876 GLYCOSYLATED HAEMOGLOBIN INCREASED 1 0.0000
877 ACNE 3 0.0000
878 GASTRIC CANCER 1 0.0000
879 HAEMATEMESIS 1 0.0000
880 CARDIOVASCULAR DISORDER 1 0.0000
881 FLUSHING 4 0.0000
882 HEPATITIS 1 0.0000
883 OFF LABEL USE 34 0.0000
884 HYPERHIDROSIS 5 0.0000
885 ANAPHYLACTIC SHOCK 1 0.0000
886 PSORIASIS 5 0.0000
887 NERVOUSNESS 2 0.0000
888 SEDATION 1 0.0000
889 DERMATITIS ATOPIC 2 0.0000
890 DEPRESSED MOOD 2 0.0000
891 MENSTRUATION IRREGULAR 1 0.0000
892 JAUNDICE 1 0.0000
893 BLOOD BILIRUBIN INCREASED 1 0.0000
894 RASH PRURITIC 2 0.0000
895 PALLOR 1 0.0000
896 ANAPHYLACTIC REACTION 2 0.0000
897 ARTHROPATHY 2 0.0000
898 GASTROINTESTINAL HAEMORRHAGE 3 0.0000
899 SEPSIS 4 0.0000
900 INJECTION SITE PAIN 11 0.0000
901 DRUG INEFFECTIVE 47 0.0000
902 OXYGEN SATURATION DECREASED 2 0.0000
903 RED BLOOD CELL COUNT DECREASED 1 0.0000
904 PANCREATIC CARCINOMA 1 0.0000
905 MUSCULOSKELETAL STIFFNESS 3 0.0000
906 PALPITATIONS 4 0.0000
907 ERYTHEMA 7 0.0000
908 ASCITES 1 0.0000
909 ACUTE MYOCARDIAL INFARCTION 1 0.0000
910 PSYCHOTIC DISORDER 1 0.0000
911 TACHYCARDIA 3 0.0000
912 IRRITABILITY 2 0.0000
913 CORONARY ARTERY DISEASE 1 0.0000
914 THERAPEUTIC RESPONSE DECREASED 2 0.0000
915 PLEURAL EFFUSION 2 0.0000
916 OEDEMA PERIPHERAL 4 0.0000
917 LIMB DISCOMFORT 1 0.0000
918 VISUAL IMPAIRMENT 4 0.0000
919 DRUG-INDUCED LIVER INJURY 1 0.0000
920 BLOOD GLUCOSE INCREASED 6 0.0000
921 PYREXIA 11 0.0000
922 LACTIC ACIDOSIS 1 0.0000
923 DEEP VEIN THROMBOSIS 2 0.0000
924 SWELLING FACE 2 0.0000
925 TREMOR 5 0.0000
926 DIZZINESS 15 0.0000
927 LIP SWELLING 1 0.0000
928 CHEST DISCOMFORT 3 0.0000
929 RASH MACULAR 1 0.0000
930 SLEEP DISORDER 2 0.0000
931 SKIN BURNING SENSATION 2 0.0000
932 ACCIDENTAL OVERDOSE 1 0.0000
933 BRONCHITIS 2 0.0000
934 EYE SWELLING 1 0.0000
935 HEPATIC FUNCTION ABNORMAL 1 0.0000
936 DISORIENTATION 1 0.0000
937 PROSTATE CANCER 2 0.0000
938 PSORIATIC ARTHROPATHY 1 0.0000
939 CARDIAC ARREST 2 0.0000
940 PRODUCT USE IN UNAPPROVED INDICATION 6 0.0000
941 COMPLETED SUICIDE 2 0.0000
942 HYPOACUSIS 1 0.0000
943 MYOCARDIAL INFARCTION 4 0.0000
944 DRUG WITHDRAWAL SYNDROME 2 0.0000
945 DEHYDRATION 3 0.0000
946 SKIN IRRITATION 1 0.0000
947 ADVERSE EVENT 2 0.0000
948 BREAST CANCER 2 0.0000
949 CARDIAC DISORDER 2 0.0000
950 DISEASE RECURRENCE 1 0.0000
951 RENAL CANCER 1 0.0000
952 COLORECTAL CANCER 1 0.0000
953 BLOOD GLUCOSE DECREASED 1 0.0000
954 CONTUSION 2 0.0000
955 HYPOGLYCAEMIA 1 0.0000
956 ALOPECIA 4 0.0000
957 AGGRESSION 1 0.0000
958 HYPOTENSION 4 0.0000
959 HAEMOGLOBIN DECREASED 2 0.0000
960 INFLAMMATION 1 0.0000
961 ECZEMA 1 0.0000
962 OVERDOSE 4 0.0000
963 PRODUCT SUBSTITUTION ISSUE 1 0.0000
964 DYSPHONIA 1 0.0000
965 CHILLS 2 0.0000
966 NASAL CONGESTION 1 0.0000
967 VOMITING 8 0.0000
968 DISCOMFORT 1 0.0000
969 CHEST PAIN 3 0.0000
970 RHINORRHOEA 1 0.0000
971 BLOOD PRESSURE DECREASED 1 0.0000
972 INJECTION SITE PRURITUS 1 0.0000
973 NEUTROPENIA 2 0.0000
974 VISION BLURRED 2 0.0000
975 DEVICE MALFUNCTION 1 0.0000
976 DYSGEUSIA 1 0.0000
977 EPISTAXIS 1 0.0000
978 HOT FLUSH 1 0.0000
979 INJECTION SITE SWELLING 1 0.0000
980 INJECTION SITE BRUISING 1 0.0000
981 INJECTION SITE HAEMORRHAGE 1 0.0000
982 DRY MOUTH 1 0.0000
983 INFLUENZA LIKE ILLNESS 1 0.0000
984 DRUG DOSE OMISSION 2 0.0000
985 NO ADVERSE EVENT 2 0.0000
986 OROPHARYNGEAL PAIN 1 0.0000
987 HEART RATE INCREASED 1 0.0000
988 SINUSITIS 1 0.0000
989 INCORRECT DOSE ADMINISTERED 2 0.0000
990 DISEASE PROGRESSION 1 0.0000
991 PRODUCT QUALITY ISSUE 1 0.0000